Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis.

Life (Basel) · 2021 · PMC8470048 · PMID 34575076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Nevertheless, Nemolizumab 60 mg Q4W in monotherapy did not reach statistical significance in the improvement of EASI 75/90 or IGA 0/1, with values of the confidence interval for OR that includes 1.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.